diazepam genoptim 10 mg/2 ml roztwór do wstrzykiwań
as grindeks - diazepamum - roztwór do wstrzykiwań - 10 mg/2 ml
clariscan 0,5 mmol/ml roztwór do wstrzykiwań w ampułko-strzykawce
ge healthcare as - acidum gadotericum - roztwór do wstrzykiwań w ampułko-strzykawce - 0,5 mmol/ml
clariscan 0,5 mmol/ml roztwór do wstrzykiwań
ge healthcare as - acidum gadotericum - roztwór do wstrzykiwań - 0,5 mmol/ml
chwastox as 600 ec
ciech sarzyna s.a_x000d_ ul. chemików, 37-310 nowa sarzyna - mcpa - mcpa - 600 g - chwastobójczy
ketoject 100 mg/ml roztwór do wstrzykiwań
interchemie werken de adelaar eesti as - ketoprofenum - roztwór do wstrzykiwań - 100 mg/ml - bydło; koń; świnia
interflox 100 mg/ml roztwór do wstrzykiwań
interchemie werken de adelaar eesti as - enrofloxacinum - roztwór do wstrzykiwań - 100 mg/ml - bydło; koza; owca; świnia
rinvoq
abbvie deutschland gmbh & co. kg - upadacitinib - zapalenie stawów, reumatoidalne - leki immunosupresyjne - rheumatoid arthritisrinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (dmards). rinvoq may be used as monotherapy or in combination with methotrexate. psoriatic arthritisrinvoq is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more dmards. rinvoq may be used as monotherapy or in combination with methotrexate. axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)rinvoq is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri), who have responded inadequately to nonsteroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)rinvoq is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy. atopic dermatitisrinvoq is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. ulcerative colitisrinvoq is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent. crohn’s diseaserinvoq is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.
lumeblue (previously known as methylthioninium chloride cosmo)
alfasigma s.p.a. - chlorek metylotioniny - colorectal neoplasms; colonoscopy - other diagnostic agents - lumeblue is indicated as a diagnostic agent enhancing visualisation of colorectal lesions in adult patients undergoing screening or surveillance colonoscopy.
calmafusion (380 mg + 60 mg + 50 mg)/ml roztwór do infuzji
interchemie werken de adelaar eesti as - calcii gluconas monohydricus + magnesii chloridum hexahydricum + acidum boricum - roztwór do infuzji - (380 mg + 60 mg + 50 mg)/ml - bydło; owca; świnia
sedachem 20,00 mg/ml (co odpowiada 23,32 mg/ml ksylazyny chlorowodorku) roztwór do wstrzykiwań
interchemie werken de adelaar eesti as - xylazini hydrochloridum - roztwór do wstrzykiwań - 20,00 mg/ml (co odpowiada 23,32 mg/ml ksylazyny chlorowodorku) - bydło; koń; kot; pies